Muthukumarasamy Raja/LinkedIn
Aug 13, 2026, 18:31
Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
Muthukumarasamy Raja, Managing Director at GeniusArena Software B.V., shared a post on LinkedIn:
“Plasma is essential in severe bleeding because it replaces lost blood volume and provides clotting factors that help stop hemorrhage.
Yet, traditional plasma was difficult to use in emergencies because it required freezing, lengthy thawing, and strict cold-chain storage.
The FDAโs 2026 approval of EZPLAZ freeze-dried plasma represents a real breakthroughย in emergency care by making plasma rapidly available where and when it is needed most.
Join JobsReach Healthcare, the healthcare industry network, to join the conversation, share your knowledge, and discover healthcare insights and opportunities.”
Stay updated with Hemostasis Today.
-
Sep 28, 2026, 16:43Scott Sutton: Community and Connection in Immune Thrombocytopenia
-
Sep 28, 2026, 16:24Pankti Solanki: ISBT Recognized JAMA as the 49th Human Blood Group System
-
Sep 28, 2026, 15:52Kassa Tameru: Antithrombotic Management in GI Bleeding and Elective Endoscopy
-
Sep 28, 2026, 15:51Chengappa Kavadichanda: How Do aPLs Change Over Time in Early Lupus?
-
Sep 28, 2026, 15:18Linda Shore-Lesserson: Celebrating 25 Years of PBM at the SABM Meeting
-
Sep 28, 2026, 14:45Access Real-Time Bleeding Disorder Guidelines with the New WFH Resource Hub – WFH
-
Sep 28, 2026, 14:44Subham Banerjee: When Routine Blood Grouping Hid a Rare Diagnosis
-
Sep 28, 2026, 14:41Francois Roubille: Can Low-Dose Colchicine Prevent Atrial Fibrillation After CABG?
-
Sep 28, 2026, 14:39William Aird: Gulliverโs Atlas – Mapping the Evolution of the Vertebrate Red Cell